Granted Patent
B2
US 9,334,276 · App. 14/370,124 · Granted May 10, 2016
Forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor
Assignee:
Novartis AG
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to a phosphate salt or a nitrate salt of 4-(R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl-3-fluoro-benzonitrile, especially in crystalline form, and specific forms of these salts, as well as related invention embodiments. The salts and salt forms allow for the prophylactic and/or therapeutic treatment of aldosterone synthase and/or aromatase mediated diseases or disorders.
Claims (1)
1. A nitrate salt of 4-(R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl-3-fluoro-benzonitrile.
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 27, 2020
From: NOVARTIS AG
To: RECORDATI AG
Reel/Frame 051945/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 9, 2014
From: SUTTON, PAUL ALLEN; LOESER, ERIC M
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 033272/0118 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 9, 2014
From: NOVARTIS PHARMACEUTICALS CORPORATION
To: NOVARTIS AG
Reel/Frame 033282/0971 →
Continuity (2)
Provisional Application
61587280
· Jan 17, 2012